Effects of dopaminergic stimulation on functional brain metabolism in rats with unilateral substantia nigra lesions

Abstract

We have studied regional cerebral glucose utilization (RCGU) in awake, unrestrained rats 21 days after unilateral substantia nigra lesions following treatment with either apomorphine (0.5 mg/kg s.c.) or d-amphetamine (2.5 mg/kg s.c.). In ‘control’ rats with a unilateral SN lesion, there was a 30–40% increase in RCGU in the ipsilateral globus pallidus (GP) and a 15–25% increase in the ipsilateral lateral habenular nucleus (LH). Apomorphine treatment produced contralateral while d-amphetamine elicited ipsilateral turning in the lesioned rats. Apomorphine administration led to an increase in RCGU in the ipsilateral striatum, entopeduncularis (EP), and substantia nigra pars reticulata (SNPR); while d-amphetamine elicited similar changes in the same structures contralateral to the lesion. Both apomorphine and d-amphetamine treatment led to bilateral increases in RCGU in the subthalamic nuclei. The increased RCGU found in the ipsilateral GP in ‘lesioned controls’ was reduced to control levels by apomorphine administration, while amphetamine treatment increased RCGU in the contralateral GP without affecting glucose utilization in the ipsilateral GP. Furthermore, apomorphine treatment markedly reduced RCGU in the LHN bilaterally while amphetamine reduced RCGU only in the contralateral LHN. The effects of apomorphine were dose-dependent. Haloperidol (1 mg/kg s.c.) pretreatment completely blocked the development of asymmetric changes in RCGU in nigral lesioned rats after apomorphine administration. These results suggest that apomorphine, a direct dopamine agonist, selectively activated basal ganglia pathways ipsilateral to substantia nigra lesion by interacting with supersensitive dopamine receptors in the ipsilateral striatum. In contrast, d-amphetamine, an indirect dopamine agonist, selectively activated pathways in the contralateral basal ganglia by releasing endogenous dopamine from the intact nigrostriatal pathway. Furthermore, the data suggest that striatal efferents to the GP are not controlled in the same manner as efferents to the EP and SNPR. Finally, these asymmetric changes in RCGU in basal ganglia structures produced by apomorphine or d-amphetamine do not appear to be a consequence of the turning behavior, but rather appear to be proximate effects of the drugs administered.